Conexeu Sciences Inc (CNXU)

$7.76 -0.55 (-6.62%)
Market Cap 222.36M
Revenue (ttm) 0.00
Net Income (ttm) -3.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 131,300
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 26.76M
Stochastic %K 23%
Beta N/A
Analysts Sell
Price Target $20.00

Company Profile

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting ther...

Industry: Biotechnology
Sector: Healthcare
Phone: (604) 315-4722
Address:
50 West Liberty Street, Suite 880, Reno, United States
fional
fional Jul. 30 at 4:52 PM
$CNXU Probably best to wait for the Full Stochastic to cross up over 20 to get a nice momo bounce and go from there. It tested the 10dma this morning and retreated; it will be a better buy signal when it is above the 10dma. No 50dma available on charts yet - too new. Speculative L/T but a nice momo bounce for S/T profit when it crosses the Stochastic noted above. GL all.
0 · Reply
cor1
cor1 Jul. 30 at 4:42 PM
$CNXU here is the marketing copy I got in the mail on conexeu.
0 · Reply
cor1
cor1 Jul. 30 at 4:39 PM
$CNXU Rich Dad / Poor Dad is pumping this one hard. And we have a daily hammer. Small cap, high risk. But probably worth riding the wave.
0 · Reply
Sarah147
Sarah147 Jul. 20 at 8:03 PM
$CNXU bottomed out?! loading some for a bounce
0 · Reply
topstockalerts
topstockalerts Jul. 15 at 5:31 PM
Top Gainers PT2 $SLSN $TGHL $KUST $CNXU $GUTS
0 · Reply
topstockalerts
topstockalerts Jul. 15 at 3:01 PM
Top Gainers PT2 $KUST $TGHL $CNXU $VTAK $APLM
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor Jul. 13 at 11:24 PM
$CNXU I got a letter in the mail from Robert Kiyosaki saying I should buy this.
1 · Reply
stocks_2watch
stocks_2watch Jul. 7 at 1:46 PM
Look…the preclinical data on their Ten-Minute Tissue injectable looks promising for wound care but $CNXU is still pre-revenue with a fast burn rate. The latest 10Q showed a $2.3M net loss for the quarter and zero revenue. expanding their footprint at the new Vancouver adMare M4 hub is a great long-term move to scale the CXU platform, preclinical biotech burns cash fast. Still have trust but being carefull
0 · Reply
Mikiminingmouse
Mikiminingmouse Jul. 3 at 3:21 PM
$CNXU Big step forward them, with opening of their new Vancouver R&D lab at the adMare hub. great to see them hit these operational milestones as they steadily build momentum toward their 2027 FDA 510(k) submission
0 · Reply
topstockalerts
topstockalerts Jul. 2 at 12:35 PM
Pre Market Top Gainers PT2 $SURG $SDEV $TENX $UPXI $CNXU
0 · Reply
Latest News on CNXU
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It

Jul 14, 2026, 8:30 AM EDT - 20 days ago

The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It

A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today's Injectables Were Not Built to Fill

Jul 7, 2026, 9:00 AM EDT - 27 days ago

A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today's Injectables Were Not Built to Fill

Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform

Jun 25, 2026, 8:30 AM EDT - 5 weeks ago

Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform

Conexeu Sciences initiated with a Buy at H.C. Wainwright

2026-06-22T10:05:06.000Z - 6 weeks ago

Conexeu Sciences initiated with a Buy at H.C. Wainwright

Conexeu Sciences appoints David Bogart as chief commercial officer

2026-06-15T13:11:02.000Z - 7 weeks ago

Conexeu Sciences appoints David Bogart as chief commercial officer

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing

Jun 15, 2026, 8:30 AM EDT - 7 weeks ago

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing

Conexeu Sciences Quarterly report: Q2 2026

Jun 15, 2026, 8:00 AM EDT - 7 weeks ago

Conexeu Sciences Quarterly report: Q2 2026

Conexeu Sciences provides update on manufacturing scale up for wound care device

2026-06-08T13:01:13.000Z - 2 months ago

Conexeu Sciences provides update on manufacturing scale up for wound care device

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program

Jun 8, 2026, 8:30 AM EDT - 2 months ago

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program

Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026

Jun 3, 2026, 8:30 AM EDT - 2 months ago

Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026

UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

May 27, 2026, 10:36 AM EDT - 2 months ago

UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

May 27, 2026, 8:30 AM EDT - 2 months ago

Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"

May 21, 2026, 12:02 PM EDT - 2 months ago

Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"

Conexeu Sciences opens at $13.50 after Nasdaq direct listing

2026-05-21T15:45:30.000Z - 2 months ago

Conexeu Sciences opens at $13.50 after Nasdaq direct listing

fional
fional Jul. 30 at 4:52 PM
$CNXU Probably best to wait for the Full Stochastic to cross up over 20 to get a nice momo bounce and go from there. It tested the 10dma this morning and retreated; it will be a better buy signal when it is above the 10dma. No 50dma available on charts yet - too new. Speculative L/T but a nice momo bounce for S/T profit when it crosses the Stochastic noted above. GL all.
0 · Reply
cor1
cor1 Jul. 30 at 4:42 PM
$CNXU here is the marketing copy I got in the mail on conexeu.
0 · Reply
cor1
cor1 Jul. 30 at 4:39 PM
$CNXU Rich Dad / Poor Dad is pumping this one hard. And we have a daily hammer. Small cap, high risk. But probably worth riding the wave.
0 · Reply
Sarah147
Sarah147 Jul. 20 at 8:03 PM
$CNXU bottomed out?! loading some for a bounce
0 · Reply
topstockalerts
topstockalerts Jul. 15 at 5:31 PM
Top Gainers PT2 $SLSN $TGHL $KUST $CNXU $GUTS
0 · Reply
topstockalerts
topstockalerts Jul. 15 at 3:01 PM
Top Gainers PT2 $KUST $TGHL $CNXU $VTAK $APLM
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor Jul. 13 at 11:24 PM
$CNXU I got a letter in the mail from Robert Kiyosaki saying I should buy this.
1 · Reply
stocks_2watch
stocks_2watch Jul. 7 at 1:46 PM
Look…the preclinical data on their Ten-Minute Tissue injectable looks promising for wound care but $CNXU is still pre-revenue with a fast burn rate. The latest 10Q showed a $2.3M net loss for the quarter and zero revenue. expanding their footprint at the new Vancouver adMare M4 hub is a great long-term move to scale the CXU platform, preclinical biotech burns cash fast. Still have trust but being carefull
0 · Reply
Mikiminingmouse
Mikiminingmouse Jul. 3 at 3:21 PM
$CNXU Big step forward them, with opening of their new Vancouver R&D lab at the adMare hub. great to see them hit these operational milestones as they steadily build momentum toward their 2027 FDA 510(k) submission
0 · Reply
topstockalerts
topstockalerts Jul. 2 at 12:35 PM
Pre Market Top Gainers PT2 $SURG $SDEV $TENX $UPXI $CNXU
0 · Reply
stocks_2watch
stocks_2watch Jun. 26 at 12:15 PM
$CNXU is scaling up the formulation tech with their CDMO for the 2027 510k submission, smooth transition from research to manufacturing so if they hits timelines this bio-tissue play is going to be massive
0 · Reply
mrrobot1337
mrrobot1337 Jun. 26 at 10:40 AM
Fresh Nasdaq debut with $CNXU and they already rang the bell this month. No royalty or licensing baggage on their IP. Highly scalable ECM platform targeting huge markets like wound care, one of those?
0 · Reply
kate8delgado8
kate8delgado8 Jun. 24 at 11:01 AM
$CNXU
0 · Reply
harrijakey
harrijakey Jun. 24 at 10:57 AM
$CNXU
0 · Reply
masonRhiiine
masonRhiiine Jun. 24 at 10:56 AM
$CNXU
0 · Reply
brennan_lucas999
brennan_lucas999 Jun. 24 at 10:55 AM
$CNXU
0 · Reply
calderinho
calderinho Jun. 24 at 10:53 AM
$CNXU
0 · Reply
Mikiminingmouse
Mikiminingmouse Jun. 23 at 3:02 PM
$CNXU good stuff
0 · Reply
mate8
mate8 Jun. 23 at 2:32 PM
$CNXU
0 · Reply
stocks_2watch
stocks_2watch Jun. 23 at 2:26 PM
$CNXU, has a Promising Webinar upcoming with their President & CEO Miles Harrison will discuss the high-growth markets Conexeu is targeting, including its recent expansion into regenerative aesthetics, sign Up: https://globalonemedia.zoom.us/webinar/register/WN_iPU1kk8VSHeyXl2xOwlKUA#/registration
0 · Reply
topstockalerts
topstockalerts Jun. 16 at 9:17 PM
$CNXU this one is sneaking up on people
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 16 at 12:51 PM
$CNXU future zero
0 · Reply